Fang, Hai http://orcid.org/0000-0003-3961-8572
,
De Wolf, Hans
Knezevic, Bogdan
Burnham, Katie L. http://orcid.org/0000-0001-8680-2933
Osgood, Julie
Sanniti, Anna
Lledó Lara, Alicia
Kasela, Silva
De Cesco, Stephane
Wegner, Jörg K.
Handunnetthi, Lahiru
McCann, Fiona E.
Chen, Liye http://orcid.org/0000-0003-1503-6017
Sekine, Takuya
Brennan, Paul E.
Marsden, Brian D. http://orcid.org/0000-0002-1937-4091
Damerell, David
O’Callaghan, Chris A. http://orcid.org/0000-0001-9962-3248
Bountra, Chas
Bowness, Paul
Sundström, Yvonne
Milani, Lili http://orcid.org/0000-0002-5323-3102
Berg, Louise
Göhlmann, Hinrich W. http://orcid.org/0000-0002-6582-5455
Peeters, Pieter J.
Fairfax, Benjamin P. http://orcid.org/0000-0001-7413-5002
Sundström, Michael
Knight, Julian C. http://orcid.org/0000-0002-0377-5536
Article History
Received: 22 November 2018
Accepted: 24 May 2019
First Online: 28 June 2019
Competing interests
: The Structural Genomics Consortium receives funds from AbbVie, Bayer Pharma, Boehringer Ingelheim, the Canada Foundation for Innovation, the Eshelman Institute for Innovation, Genome Canada, Janssen, Merck (Darmstadt, Germany), MSD, Novartis Pharma, the Ontario Ministry of Economic Development and Innovation, Pfizer, the São Paulo Research Foundation, Takeda and the Wellcome Trust (authors B.D.M., D.D., C.B., Y.S., L.B. and M.S.). These funders had no direct role in study conceptualization, design, data collection, analysis, decision to publish or preparation of the manuscript, except for Janssen (authors H.D.W., J.K.W., H.W.G. and P.J.P.), which generated the L1000 data in house for the compound screen presented in the paper.